Global Health and Life Sciences Newsletter Edition 11
Updates in a heartbeat
10 lutego 2025
Global Health and Life Sciences Newsletter Edition 11Updates in a heartbeat10 lutego 2025 Welcome to the latest edition of “Updates in a heartbeat”. Our newsletter provides you with a compilation of key legal developments over the last few months. Our latest edition delves into topics covering the EU adopted Directive 2024/2853 on product liability, modernizing rules to cover digital goods, software, and AI-driven products. In the UK, the MHRA opened applications for an AI regulatory sandbox to address challenges in regulating AI medical devices and secured a £400 million investment to boost clinical trials and improve the manufacturing of medicinal products. We hope you enjoy our latest newsletter and please do reach out to us if you would like to discuss any of the issues in more detail. Ostatnie Publikacje
Ostatnie Aktualności
Ostatnie Konferencje i szkoleniaklienci i projekty 02 czerwca 2026 Next stop, public ownership: Eversheds Sutherland advises DfT on GTR transi... aktualności firmowe 01 czerwca 2026 Eversheds Sutherland strengthens restructuring offering with senior partner... aktualności firmowe 01 czerwca 2026 Eversheds Sutherland strengthens Commercial Advisory practice with technolo... klienci i projekty 28 maja 2026 Eversheds Sutherland advises Schroders Greencoat on acquisition of Dutch bi... |